Aravindhan Ganesan
519-888-4567 x21325
Location: 
PHR 3010A

[Science Direct] August 10, 2018 "Revealing the atomistic details behind the binding of B7–1 to CD28 and CTLA-4: A comprehensive protein-protein modelling study"

[Nature] August 27, 2019 "Comprehensive in vitro characterization of PD-L1 small molecule inhibitors"

Group(s): 
Application Areas→Cancer, Diabetes, Neurodegenerative Diseases, Virtual Reality; Technology Areas→Computational Modeling, Drug Development, Therapeutics; Discipline Areas→Biochemistry, Bioinformatics, Biophysics; Faculty→Science

Contacts by group